Somatic mutations within the exonuclease proofreading domain (EDM) of the DNA polymerase Pol ε (POLE) gene are increasingly being discovered in ovarian, colorectal, urological, and, especially, endometrial carcinoma (EC), where these are found in up to 10% of the cases. The gene discussed is POLE; the disease is endometrial carcinoma.